This training program is intended to train the individual in the areas of emerging viral infectious disease as well as the development and application of viral oncolytics. The program aims to provide the trainee with basic knowledge and hands-on experience on viruses and the associated laboratory techniques that are required for the understanding of viral pathogenesis and the use of viral oncolytics as a novel treatment against human cancers. Specifically, the trainee will undergo rigorous training in the basic techniques in genetic cloning, cell culture, virus culture, cell transfection, cell cytotoxicity analysis, western blotting, immunofluorescence, microscopy, flow cytometry, drug screening analysis, and oncolytic viral assays. The trainee will also learn how to develop model systems for studying emerging viral infectious diseases and engineer oncolytic vectors for oncolytic virotherapy.